SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 6 C, 2000, Pages 4721-4726

Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer

(9) Shin, E a Ishitobi, M a Hiraoia, M a Kazumasa, F a Hideyuki, M a Nishisho, I a Toshiro, S a Yasunori, H a Tosimasa, T a

a OSAKA NATIONAL HOSPITAL (Japan)

Author keywords

Breast cancer; Docetaxel; Metastasis

Indexed keywords

DOCETAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ALOPECIA; ARTICLE; ASTHENIA; BREAST CANCER; BREAST METASTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATITIS; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAXIMUM TOLERATED DOSE; NAIL DISEASE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN TOXICITY;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASTHENIA; BREAST NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EDEMA; FATIGUE; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEUTROPENIA; PACLITAXEL; TAXOIDS;

EID: 0034493039 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (16)

References (21)

1
- 0028824166
- Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2879-2885
- Ravdin, P.M.¹ Burris III, H.A.² Cook, G.³ Eisenberg, P.⁴ Kane, M.⁵ Bierman, W.A.⁶ Mortimer, J.⁷ Genevois, E.⁸ Bellet, R.E.⁹

2
- 0028827482
- Phase II trial of docetaxel: A new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2886-2894
- Valero, V.¹ Holmes, F.A.² Walters, R.S.³ Theriault, R.L.⁴ Esparza, L.⁵ Fraschini, G.⁶ Fonseca, G.A.⁷ Bellet, R.E.⁸ Buzdar, A.U.⁹ Hortobagyi, G.N.¹⁰

3
- 9244261066
- Docetaxel: An active drug for squamous cell carcinoma of the head and neck
- (1996) J Clin Oncol , vol.14 , pp. 1672-1678
- Dreyfuss, A.I.¹ Clark, J.R.² Norris, C.M.³ Rossi, R.M.⁴ Lucarini, J.W.⁵ Busse, P.M.⁶ Poulin, M.D.⁷ Thornhill, L.⁸ Costello, R.⁹ Posner, M.R.¹⁰

4
- 23444459189
- Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
- (1994) J Clin Oncol , vol.12 , pp. 1238-1244
- Fossella, F.V.¹ Lee, J.S.² Murphy, W.K.³ Lippman, S.M.⁴ Calayag, M.⁵ Pang, A.⁶ Chasen, M.⁷ Shin, D.M.⁸ Glisson, B.⁹ Benner, S.¹⁰

5
- 0027999654
- Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer
- (1994) J Clin Oncol , vol.12 , pp. 2301-2308
- Francis, P.¹ Schneider, J.² Hann, L.³ Balmaceda, C.⁴ Barakat, R.⁵ Phillips⁶ Hakes, T.⁷

6
- 0025804190
- Relationships between the structure of taxol analogues and their antimitotic activity
- (1991) J Med Chem , vol.34 , pp. 992-998
- Gueritte-Voegelein, F.¹ Guenard, D.² Lavelle, F.³ Le Goff, M.T.⁴ Mangatal, L.⁵ Potier, P.⁶

7
- 0028175036
- Paclitaxel (Taxol) and docetaxel (Taxotere): Not simply two of a kind
- (1994) Ann Oncol , vol.5 , pp. 495-505
- Verweij, J.¹ Clavel, M.² Chevalier, B.³

8
- 0028837396
- Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: A phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer
- (1995) J Clin Oncol , vol.13 , pp. 314-322
- Chevallier, B.¹ Fumoleau, P.² Kerbrat, P.³ Dieras, V.⁴ Roche, H.⁵ Krakowski, I.⁶ Azli, N.⁷ Bayssas, M.⁸ Lentz, M.A.⁹ Van Glabbeke, M.¹⁰

9
- 9444258045
- A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: Report of the Clinical Screening Group of the EORTC
- European Organization for Research and Treatment of Cancer
- (1996) Br J Cancer , vol.74 , pp. 650-656
- Dieras, V.¹ Chevallier, B.² Kerbrat, P.³ Krakowski, I.⁴ Roche, H.⁵ Misset, J.L.⁶ Lentz, M.A.⁷ Azli, N.⁸ Murawsky, M.⁹ Riva, A.¹⁰ Pouillart, P.¹¹ Fumoleau, P.¹²

10
- 0030048914
- Docetaxel in patients with metastatic breast cancer: A phase II study of the National Cancer Institute of Canada-Clinical Trials Group
- (1996) J Clin Oncol , vol.14 , pp. 422-428
- Trudeau, M.E.¹ Eisenhauer, E.A.² Higgins, B.P.³ Letendre, F.⁴ Lofters, W.S.⁵ Norris, B.D.⁶ Vandenberg, T.A.⁷ Delorme, F.⁸ Muldal, A.M.⁹

11
- 0030051216
- Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer
- (1996) J Clin Oncol , vol.14 , pp. 58-65
- Hudis, C.A.¹ Seidman, A.D.² Crown, J.P.³ Balmaceda, C.⁴ Freilich, R.⁵ Gilewski, T.A.⁶ Hakes, T.B.⁷ Currie, V.⁸ Lebwohl, D.E.⁹ Baselga, J.¹⁰ Raptis, G.¹¹ Gollub, M.¹² Robles, M.¹³ Bruno, R.¹⁴ Norton, L.¹⁵

12
- 0028260937
- A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group
- (1994) Ann Oncol , vol.5 , pp. 527-532
- Ten Bokkel Huinink, W.W.¹ Prove, A.M.² Piccart, M.³ Steward, W.⁴ Tursz, T.⁵ Wanders, J.⁶ Franklin, H.⁷ Clavel, M.⁸ Verweij, J.⁹ Alakl, M.¹⁰ Bayssas, M.¹¹ Kaye, S.B.¹²

13
- 0031758794
- A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer
- (1998) J Clin Oncol , vol.16 , pp. 3362-3368
- Valero, V.¹ Jones, S.E.² Von Hoff, D.D.³ Booser, D.J.⁴ Mennel, R.G.⁵ Ravdin, P.M.⁶ Holmes, F.A.⁷ Rahman, Z.⁸ Schottstaedt, M.W.⁹ Erban, J.K.¹⁰ Esparza-Guerra, L.¹¹ Earhart, R.H.¹² Hortobagyi, G.N.¹³ Burris III, H.A.¹⁴

14
- 18144450345
- Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent gastric cancer: A Japanese Cooperative Study Group trial
- Japanese
- (1998) Gan To Kagaku Ryoho , vol.25 , pp. 1915-1922
- Taguchi, T.¹ Sakata, Y.² Kanamaru, R.³ Kurihara, M.⁴ Suminaga, M.⁵ Ota, J.⁶ Hirabayashi, N.⁷

15
- 0030040267
- A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer
- (1996) Br J Cancer , vol.73 , pp. 210-216
- Adachi, I.¹ Watanabe, T.² Takashima, S.³ Narabayashi, M.⁴ Horikoshi, N.⁵ Aoyama, H.⁶ Taguchi, T.⁷

16
- 0031757277
- Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer
- (1998) J Clin Oncol , vol.16 , pp. 3353-3361
- Seidman, A.D.¹ Hudis, C.A.² Albanel, J.³ Tong, W.⁴ Tepler, I.⁵ Currie, V.⁶ Moynahan, M.E.⁷ Theodoulou, M.⁸ Gollub, M.⁹ Baselga, J.¹⁰ Norton, L.¹¹

17
- 0003198490
- A large phase II trial of paclitaxel administered as a weekly one hour infusion in patients with metastatic breast cancer
- abst
- (1999) Proc Am Soc Clin Oncol , vol.18
- Perez, E.A.¹ Irwin, D.H.² Patel, R.³ Vogel, C.L.⁴ Kirshner, J.⁵

18
- 0031800526
- Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
- (1998) J Clin Oncol , vol.16 , pp. 2164-2168
- Hainsworth, J.D.¹ Burris III, H.A.² Erland, J.B.³ Thomas, M.⁴ Greco, F.A.⁵

19
- 0029148461
- Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer
- (1995) J Clin Oncol , vol.13 , pp. 2575-2581
- Seidman, A.D.¹ Tiersten, A.² Hudis, C.³ Gollub, M.⁴ Barrett, S.⁵ Yao, T.J.⁶ Lepore, J.⁷ Gilewski, T.⁸ Currie, V.⁹ Crown, J.¹⁰ Hakes, T.¹¹ Baselga, J.¹² Sklarin, N.¹³ Moynihan, M.E.¹⁴ Tong, W.¹⁵ Egorin, M.¹⁶ Kearns, C.¹⁷ Spriggs, D.¹⁸ Norton, L.¹⁹

20
- 0034061842
- Docetaxel administered on a weekly basis for metastatic breast cancer
- (2000) J Clin Oncol , vol.18 , pp. 1212-1219
- Horlod, J.B.¹ Manola, J.² Younger, J.³ Parker, L.M.⁴ Bunnell, C.A.⁵ Scheib, R.⁶ Matulonis, U.A.⁷ Garber, J.E.⁸ Clarke, K.D.⁹ Shulman, L.N.¹⁰ Winer, E.P.¹¹

21
- 0026425674
- Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue
- (1991) Cancer Res , vol.51 , pp. 4845-4852
- Bissery, M.C.¹ Guenard, D.² Gueritte-Voegelein, F.³ Lavelle, F.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.